Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
about
Doripenem Treatment during Continuous Renal Replacement TherapyPopulation Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock.Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy.
P2860
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@en
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@nl
type
label
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@en
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@nl
prefLabel
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@en
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@nl
P2093
P2860
P50
P356
P1476
Doripenem population pharmacok ...... venovenous haemodiafiltration.
@en
P2093
Janine Stuart
Juergen B Bulitta
Melissa Lassig-Smith
Natasha A Roberts
Paul Jarrett
Rachel Dunlop
Steven C Wallis
Therese Starr
Yoshiro Hayashi
P2860
P304
P356
10.1093/JAC/DKU177
P407
P577
2014-05-30T00:00:00Z